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Introduction: An issue of recent research interest is excessive stoma output and its relation to electrolyte abnormalities.
Some studies have identified this as a precursor of dehydration and renal dysfunction. A prospective study was
performed of the complications associated with high-output stomas, to identify their causes, consequences
and management.
Materials and methods: This study was carried out by a multidisciplinary team of surgeons, gastroenterologists,
nutritionists and hospital pharmacists. High-output stoma (HOS) was defined as output ≥1500 ml for two consecutive
days. The subjects included in the study population, 43 patients with a new permanent or temporary stoma, were
classified according to the time of HOS onset as early HOS (<3 weeks after initial surgery) or late HOS (≥3 weeks after
surgery). Circumstances permitting, a specific protocol for response to HOS was applied. Each patient was followed up
until the fourth month after surgery.
Results: Early HOS was observed in 7 (16 %) of the sample population of 43 hospital patients, and late HOS, in 6 of the
37 (16 %) non-early HOS population. By type of stoma, nearly all HOS cases affected ileostomy, rather than colostomy,
patients. The patients with early HOS remained in hospital for 18 days post surgery, significantly longer than those w
ith no HOS (12 days). The protocol was applied to the majority of EHOS patients and achieved 100 % effectiveness.
50 % of readmissions were due to altered electrolyte balance. Hypomagnesaemia was observed in 33 % of the late
HOS patients.
Conclusion: The protocol developed at our hospital for the detection and management of HOS effectively addresses
possible long-term complications arising from poor nutritional status and chronic electrolyte alteration.
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The most common causes of intestinal resection in adults
are aggressive secondary surgery for vascular and neoplas-
tic disease, and the sequelae of Crohn’s disease with poor
pharmacological control [1]. Many of these resections re-
quire the construction of a stoma, a surgically-created
opening in the abdomen for the discharge of faecal
contents, to protect a fragile anastomosis, to manage
incontinence or, in the case of certain temporary ostomies,
to alleviate symptoms [2].* Correspondence: jjavier.arenas@gmail.com
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unless otherwise stated.However, creating a stoma can, in itself, provoke peri-
operative and postoperative complications, with an esti-
mated incidence of 20–60 % [3, 4]. Local complications
that have commonly been reported include peristomal
skin damage, infections, parastomal hernia, stenosis, re-
traction, prolapse and peristomal varices, which have been
associated with high rates of morbidity and mortality [5].
An issue of recent research interest is excessive output
from the stoma and its relation to electrolyte abnormal-
ities. Some studies have identified this complication as a
precursor of dehydration and renal dysfunction, with an
estimated incidence of 1–17 %. It is believed to be the
cause of 4–43 % of hospital readmissions [3, 6].
High output stomas (HOS) are normally managed by
identifying the cause and by treatment consisting of then Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Treatment protocol for high output stomas
Detection and treatment of the underlying cause
Before initiating pharmacological and nutritional treatment, the
underlying cause of the HOS must be detected and treated:
• Gastrointestinal infections (after tissue culture assay to rule out
Clostridium difficile infection)
• Related to the medication:
• Prokinetic indicated drugs: metoclopramide, laxatives, erythromycin, etc.
• Abrupt withdrawal of corticosteroids
• Metformin also provokes increased stoma output
• Bowel obstructions
• Intra-abdominal sepsis
• Inflammatory bowel disease
• Short bowel syndrome
Stage I: Initial treatment:
reduction of fluid and
electrolyte loss
▪ Restrict fluid intake to 500–1000 ml/day.
Isotonic drinks are the best option. Avoid
the intake of hypotonic drinks, tea, coffee,
alcohol and fruit juices.
▪ Perform intravenous hydration.
▪ Prescribe loperamide 2 mg before
breakfast-lunch-dinner and at night.
▪ Monitoring: strict fluid balance, check
body weight daily, perform complete
blood analysis including electrolytes
(magnesium, calcium, phosphorus,
potassium and sodium).
• Start oral or I/V supplementation of
electrolytes if necessary, according to
analysis results.
▪ Start nutritional assessment and
treatment (see below).
▪ Determine B12 levels in patients who
are NOT recently operated on.
▪ Determine stoma output at 48–72 h: if it
is resolved, increase oral fluid intake and
start serum therapy and the withdrawal
of medication.
Stage II: If HOS continues,
perform follow up treatment
▪ Continue the fluid intake restriction and
the nutritional monitoring. Start SueroOral
intake (2.5 g NaCl, 1.5 g KCl, 2.5 g HCO3Na,
1.5 g sugar and 1 L water) as the only
oral source of fluids (500–1000 ml/day).
▪ Increase loperamide dose to 4 mg before
breakfast-lunch-dinner and at night
(maximum 16 mg/day).
▪ Start treatment with omeprazole 20 mg/day.
If already prescribed, increase to 40 mg/day.
▪ If fat malabsorption, steatorrhoea, or
pruritic bilious output is present, add
cholestyramine 4 g/12 before breakfast
and dinner.
▪ Continue monitoring and electrolyte
supplementation if necessary, as in Stage I.
▪ If HOS persists after 48–72 h, initiate Stage III.
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electrolytes, antisecretory and antidiarrheal medication,
nutritional and psychological support [7]. However, there
is little information about HOS and most studies report-
ing rates of complications and mortality following the
creation of a stoma do not inform of the incidence,
causes and management of HOS.
Hospital readmissions by patients who have undergone
colorectal surgery are frequent and costly [8], and HOS
are known to delay patient recovery after surgery. Further-
more, HOS constitute a frequent complication in ileos-
tomy patients and are poorly identified; in consequence,
the clinical approach adopted is often inadequate. In this
prospective study, we examine HOS and identify their
possible causes, consequences and management.
Materials and methods
A prospective, analytical study of a cohort of all patients
who underwent surgery resulting in a stoma was carried
out. Patients of both sexes, aged 18 years and over, were
included. Patients who had undergone previous ostomies
were excluded, as were patients who, after surgery,
required intensive care for more than 7 days, and those
who did not give written informed consent.
Assuming a prevalence of HOS in the overall population
of 16 % [7], a sample with 50 patients would achieve a
statistical power of over 80 %, for alpha = 0.05. Therefore,
50 patients were recruited after their surgery. All subjects
gave their written informed consent. The study was ap-
proved by the Hospital’s Ethics Committee, and adhered
in all respects and at all times to the Helsinki Declaration.
HOS was defined as ostomy output ≥1500ml for two
consecutive days [7, 9, 10]. The patients were classified as
early or late according to the time of onset of HOS [7]:
Early HOS (EHOS): Patients who developed HOS in
the postoperative phase (<3 weeks after stoma
formation), normally before hospital discharge.
Late HOS (LHOS): Patients who developed
HOS ≥ 3 weeks after stoma formation.
A multidisciplinary team of surgeons, gastroenterolo-
gists, nutritionists and hospital pharmacists was estab-
lished, and a protocol for response to HOS was designed
[11] (Table 1).
Stoma output was measured for all patients included
in the study, carried out over a postoperative follow-up
period of four months. Any readmissions needed during
this period were recorded.
The descriptive analysis was performed using mea-
sures of position and central tendency (median and
interquartile range) for quantitative variables and the
frequency distribution for qualitative variables. Variables
were compared by the chi-square test (or Fisher’s exact
Table 1 Treatment protocol for high output stomas (Continued)
Stage III. If HOS persists,
evaluate treatment and
case management
▪ Supplement with hydro- and lipid-soluble
oral vitamins.
▪ Maintain loperamide and add codeine
15–60 mg. before breakfast-lunch-dinner.
Contraindicated if the patient has
CrCl <15 ml/min.
▪ If fat malabsorption persists, increase
cholestyramine dose to 4 g before
breakfast-lunch-dinner.
▪ If HOS > 2000 ml after two weeks:
add octreotide 200 mcg/day for 3–5 days.
If no improvement is obtained, suspend
this treatment.
▪ Monitor fluid intake.
Specific nutritional treatment
▪ Avoid fluid intake during meals.
▪ It may be advisable to temporarily increase the salt content of foods in
order to promote fluid reabsorption.
▪ Little is known about the use of soluble fibre. Insoluble fibre is
contraindicated because of the risk of bowel obstruction.
▪ The effect of antidiarrhoeal microorganisms on HOS is unknown.
Table 2 General characteristics of the population
Baseline characteristics Total patients (n = 43)
Sex (female/male) 39.5/60.5 %
Age (median, years) 66 (IR 58–73)
Cause of resection
• Neoplasia 74.4 %
• Inflammatory bowel disease 14.0 %
• Benign pathologies 11.6 %
BMI pre-surgery 23.9 (IR 21.0–28.5)
Variation in BMI at discharge −0.8 [IR (−2.6)−0.0]
Comorbidities:
• Diabetes 16.3 %
• Dyslipidaemia 23.3 %
• COPD 4.8 %
• Hypothyroidism 4.7 %
• Hypertension 39.5 %
Intervention (Urgent/elective) 48.8/51.2 %
Type of stoma (Ileostomy/Colostomy) 46.5/53.5 %
Diagnosis of malnutrition 32.6 %
• Calorie
○ mild 4.7 %
• Protein-Energy
○ mild 2.3 %
○ moderate 18.6 %
○ severe 7.0 %
Neoadjuvant chemoradiation
• Chemotherapy 13 %
• Radiotherapy 6 %
• Chemoradiotherapy 12 %
• None 69 %
Post-surgery hospital stay (median, days) 13 (IR 9–17)
BMI: Body Mass Index, COPD: Chronic Obstructive Pulmonary Disease, IR:
Interquartile range
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qualitative variables and the Mann–Whitney U test for
the quantitative ones. In all analyses, the level of statis-
tical significance was set at p < 0.05.
Results
Of the 50 patients recruited at the outset, 7 were lost to
follow up. Hence, the statistical analysis was performed
on a final sample of 43 patients; of these, 63 % were
male, with a median age of 66 years (range 58–73).
Colorectal cancer was the most common indication
for the formation of a stoma. With respect to the type of
surgical intervention, a small majority of cases required
a colostomy, and an ileostomy was created in the other
cases. Almost half of the interventions were performed
as an urgent procedure. Table 2 describes the general
characteristics of the study population.
High-output stoma
16 % of patients had EHOS and 14 % had LHOS. Table 3
shows the characteristics of the patients with EHOS,
LHOS and no HOS. The median period elapsed from
surgery to the appearance of EHOS was eight days. The
underlying cause of high output was prokinetic agents
(14 %), infection (43 %) and unknown (43 %).
The protocol was applied to five of the seven EHOS
patients. In one case, it was not applied due to spontan-
eous resolution and in the other, because the patient was
lost to follow up. In four of the five to whom it was ap-
plied, the HOS was resolved in Phase I protocol, and inthe remaining one it was resolved in Phase II (Table 1).
These patients received pharmacological support and
nutritional recommendations for the control of their
HOS, according to the standard protocol [11].
The patients who had postoperative EHOS remained in
hospital for 18 days, a significantly longer period than
those who did not suffer this complication (12 days) (U =
53.00; p = 0.02). With respect to the outcome variables, al-
though the difference was not significant, there was a
higher rate of infections among the patients with EHOS
(57.1 % vs. 31.4 %; χ2 = 1.68; p = 0.23). The following vari-
ables presented no statistical differences between patients
with EHOS and no HOS: age (U = 102.00; p = 0.45), sex
(χ2 = 2.23; p = 0.22), reason for surgical intervention (χ2 =
1.40; p = 0.50), emergency surgery (χ2 = 0.12, p = 1.00),
Table 3 Characteristics of the population with HOS (Early and Late) and the comparison with no HOS population
Baseline characteristics Patients without early
HOS (n = 36)
Patients with early
HOS (n = 7)
p Patients without early
or late HOS (n = 31)
Patients with late
HOS (n = 6)
p
Sex (female/male) 44.4/55.6 % 14.3/85.7 % p = 0.22 45/56 % 33.3/66.7 % p = 0.68
Age (median, years) 66 (IR 58–74) 64 (IR 57–68) p = 0.44 66 (IR 59–74) 70 (IR 29–75) p = 0.93
Cause of resection
• Neoplasia 71 % 86 %
p=0.50
71 % 83 %
p=0.47• IBD 17 % 0 % 16 % 17 %
• Benign pathologies 12 % 14 % 13 % 0 %
BMI pre-surgery or readmission 23.9 (IR 21.1–27.2) 24.4 (IR 20.7–33.1) p = 0.55 23.9 (IR 20.4–28.5) 23.1 (IR 19.7–29.4) p = 0.68
Variation in BMI at discharge −0.6 [IR (−2.4)−(0.0)] −1.5 [IR (−3.4)−(−0.4)] p = 0.22 - - -
Length of resection (median, cm) 24.7 (IR 18.9–46.8) 24.5 (IR 19.5–40.0) p = 0.82 24.7 (IR 19.5–46.8) 19.5 (IR 16.4–85.0) p = 0.72
Intervention (Urgent/Elective) 50/50 % 43/57 % p = 1.00 48/52 % 50/50 % p = 1.00
Type of stoma (Ileostomy/Colostomy) 36/64 % 100/0 % p = 0.002 29/71 % 83/17 % p = 0.02
Infection post-surgery 31 % 57 % p = 0.23 - - -
Presence of ileocaecal valve 72 % 71 % p = 1.00 71 % 83 % p = 1.00
IBD: Inflammatory bowel disease, BMI: Body Mass Index, IR: Interquartile range
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trition (χ2 = 0.01, p = 1.00). Regarding the type of ostomy,
all of the EHOS and 83 % of the LHOS cases affected pa-
tients with ileostomy (χ2 = 9.62; p = 0.002 and χ2 = 6.30;
p = 0.02, respectively). Thus, the location of the stoma is
of evident significance.
The median period from surgery to the appearance of
LHOS was 25 days. The protocol was applied to 33 % of
LHOS patients (all resolved in Phase I). The rest did not
receive protocol care because they were readmitted for
non-general surgery services (Internal Medicine and
Emergency). The underlying cause of the LHOS was not
detected in any of these cases. 50 % of these patients
were given pharmacological support and nutritional rec-
ommendations by clinicians to control the high output
at discharge. However, 17 % were given erroneous rec-
ommendations based on increasing fluid intake, and no
pharmacological control was recommended to control
the high output.
Readmission
28 % of the stoma patients were subsequently readmitted
to hospital, with a mean weight loss from discharge to
readmission of 5.2 ± 2.3 kg. In 50 % of the patients who
were readmitted for LHOS, the principal cause was
altered electrolyte balance and dehydration. Electrolyte
abnormalities were detected in 100 % of these patients
on readmission. Magnesium levels were monitored in
three of the six LHOS, and hypomagnesaemia was
observed in two patients.
No differences were found between LHOS and no HOS
patients regarding the following variables related to readmis-
sion: age (U = 91.00; p = 0.93), gender (χ2 = 0.29; p = 0.68),
cause of surgical intervention (χ2 = 0.88; p = 0.47), urgentsurgery (χ2 = 0.01; p = 1.00), absence of ileocaecal valve
(χ2 = 0.39; p = 1.00), neoadjuvant chemotherapy (χ2 = 3.18;
p = 0.11), neoadjuvant radiotherapy (χ2 = 1.41; p = 0.27),
BMI at discharge U = 75.00, p = 0.68), or malnutrition
(χ2 = 1.22, p = 0.58).
Discussion
The need to construct a stoma often arises in clinical
practice [3]. According to statistical records, 1.5 per
thousand of the Spanish population (i.e., 60,000 patients)
live with a stoma. Taking the age factor into account, the
incidence of stoma corresponds to over 3 per thousand
of the adult population in Spain. In other Western coun-
tries, figures of 2–4 per thousand of the adult population
[12] have been reported.
In our study population, colorectal cancer was the
most common reason for a stoma being needed (65.1 %
of cases); this finding is consistent with results reported
elsewhere [3, 5].
During the first days after the construction of an
ostomy, faecal effluent usually increases, but it decreases
rapidly following intestinal adaptation [13]. When this
adaptation fails or is prolonged, patients must face the
challenge of controlling large losses of fluid that can lead
to a state of chronic dehydration [14]. When these losses
occur, ostomy patients present major deficits of water,
sodium and magnesium [15] and can also suffer malnu-
trition and long-term weight loss. This event is known
as HOS, and among stoma patients our study revealed a
prevalence of EHOS of 16 %, which is consistent with
Baker et al. [7]. These same authors identified the under-
lying cause of HOS in 50 % of cases, and noted the pres-
ence of short bowel syndrome, treated by medication,
and subsequent intestinal obstruction. In our study, the
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with drug treatment or the presence of infection being
mainly responsible for the occurrence of EHOS. None of
the patients presented short bowel syndrome.
It has been reported that HOS tend to occur more fre-
quently after emergency surgery [16], but we observed
no such association. There was a relationship between
infections and the presence of EHOS, but it was not
statistically significant [17]. On the other hand, there
were significant differences according to the type of
ostomy, for both EHOS and LHOS when an ileostomy
was performed. This finding corroborates an earlier
meta-analysis of all complications arising from ostomies
– classifying the latter as colostomy or ileostomy – which
concluded that only HOS presented significant differ-
ences, being more common following an ileostomy [18].
We compared HOS and non-HOS patients, and found
no significant differences in the universal defining vari-
ables, or with regard to the causes that led to the surgi-
cal intervention. Despite the importance of the presence
of the ileocaecal valve in retaining stoma output and that
of the secretion of hormones favouring intestinal adapta-
tion after surgical resection [1], we observed no differ-
ences with regard to the development of high output.
Neither were there significant differences between pa-
tients who received prior chemotherapy or radiotherapy,
as have been described by Hayden et al. [8]. However,
we did find significant differences with respect to the
longer hospital stay required by patients with HOS, thus
confirming the results of Harris et al. [3].
With respect to the outcome variables, patients with
HOS presented a sharper decrease in BMI at hospital
discharge and a higher rate of infections. The latter has
been reported to be one of the risk factors associated
with the occurrence of HOS [19]. There were no signifi-
cant alterations in the electrolyte profile in patients with
EHOS, and no hypomagnesaemia was detected at first
hospital admission in any patient, in contrast to the
45 % of hypomagnesaemias reported by Baker [7].
An interesting finding is that EHOS appears, on
average, eight days after resection. This highlights the
importance of instructing the patient in this respect
before hospital discharge, especially in cases of early
discharge when the condition has evolved favourably.
Several papers have commented on the importance of
these patients being instructed and informed by a multi-
disciplinary nutrition team including pharmacists, nutri-
tionists, nurses and surgeons [17, 20, 21], while the
NICE guidelines for ostomy patients state that they
should be examined every 2–3 months by a nutritional
team after the surgical intervention [22].
The early examination and treatment protocol devel-
oped for these patients (Table 1) was applied to the major-
ity of patients with HOS and achieved 100 % effectiveness.In clinical practice, it is important to test for Clostridium
difficile in order to detect the underlying cause of high
output, as an increasing number of cases of diarrhoea have
been associated with this agent during hospitalization,
which affects 3–10 patients per 1000 hospitalizations [23].
Moreover, studies have reported cases of colonisations in
the small intestine causing high output in patients with
ileostomy [24, 25]. As part of the above protocol, nutri-
tional and pharmacological recommendations were made
to 83 % of EHOS patients and to 50 % of the LHOS pa-
tients, who were thus enabled to achieve self-management
of stoma output. This outcome represents a significant
improvement in our hospital, where a previous retrospect-
ive study had noted a complete absence of recommenda-
tions to patients on hospital discharge [26].
The proportion of ostomy patients who were readmit-
ted with altered electrolyte balance and dehydration be-
cause of LHOS was 50 %, much higher than the 5.5 %
reported by Baker [7], but similar to that reported in
other studies, which have recorded 20–43 % of readmis-
sions due to dehydration related to fluid losses through
the stoma [8]. Ileostomy is considered a risk factor for
kidney failure [27]. In our study, 50 % of kidney failures
were secondary to stoma losses, which is in accordance
with the 30–71 % of the patients with HOS reported
elsewhere to have developed acute kidney failure sec-
ondary to dehydration [8]. In our study, the cause of
LHOS was not determined in any patient, nor were tests
applied to detect the presence of Clostridium difficile.
The protocol was only applied in 33 % of LHOS cases,
all of whom were patients admitted by the Surgery Ser-
vice, where personnel had been previously instructed
with respect to HOS and the recommended treatment.
Among these 33 %, the follow up rate was 100 %. More-
over, the existence of this protocol enabled nutritional
and pharmacological recommendations to be made on
hospital discharge to 50 % of the patients admitted for
surgery or nephrology. However, 17 % of stoma patients
received recommendations contrary to those contained
in the literature on the subject and were given no
pharmacological treatment to control the stoma output.
A study published in 2012 examined the rate of readmis-
sions due to dehydration among patients with ileostomy,
comparing two periods, one of which included the im-
plementation of a perioperative protocol of patient edu-
cation on how HOS should be managed; this study
reported a significant reduction in the rate of readmis-
sions, although there were no significant differences in
the duration of hospital stay [28]. In our opinion, HOS
management should be extended throughout the med-
ical service in order to improve the care provided for
ostomy patients care during readmissions.
Decreased levels of Mg in plasma are very common
following an intestinal resection, due to the consequent
Arenas Villafranca et al. Nutrition Journal  (2015) 14:45 Page 6 of 7reduction in absorption surface area and to chelation
with fatty acids [29, 30]. This condition can affect up to
45 % of patients with HOS due to hypoaldosteronism
secondary to surgery and often appears in long-term
HOS [7]. Unfortunately, it is not often monitored as
routine clinical practice in Spain. Another common con-
sequence is the appearance of electrolyte alterations
such as hypokalaemia and hypocalcaemia, both of which
are refractory to treatment until the Mg deficit is cor-
rected. Thus, some of our patients presented simultan-
eous deficits of Mg, Na, K and P.
A limitation of this study is the small sample size,
which means that the conclusions drawn cannot be
considered definitive.
Conclusions
A review of stoma output should be included in stand-
ard clinical practice, in view of the comorbidity of this
condition, which is demonstrated in the present study.
The protocol developed at our hospital for the detection
and management of HOS has proved to be effective in
addressing possible long-term complications arising from
poor nutritional status and chronic electrolyte alterations,
which may provoke severe consequences among the
patients affected.
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